Want to see CATX full AI Analyst Report?
Perspective Therapeutics (CATX) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [203Pb]Pb-Psv359, [212Pb]Pb-Psv359 | Ovarian Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Sarcoma, Gastric Cancer, Esophageal Cancer, Head And Neck Cancer, Mesothelioma | phase1AndPhase2 | Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors | Nov 25, 2024 | ― |
| Nivolumab, [203Pb]Vmt01, [212Pb]Vmt01 | Metastatic Melanoma, Melanoma Stage Iii, Melanoma Stage Iv, Recurrent Melanoma (Skin) | phase1AndPhase2 | Recruiting | MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma | Nov 15, 2022 | ― |
| [203Pb]Vmt-Α-Net, [212Pb]Vmt-Α-Net | Gastroenteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Bronchial Neuroendocrine Tumor, Paraganglioma, Pheochromocytoma | phase1AndPhase2 | Recruiting | Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors | Nov 15, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| [203Pb]Pb-Psv359, [212Pb]Pb-Psv359 | phase1AndPhase2 | Ovarian Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Sarcoma, Gastric Cancer, Esophageal Cancer, Head And Neck Cancer, Mesothelioma | Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors | Nov 25, 2024 | ― |
| Nivolumab, [203Pb]Vmt01, [212Pb]Vmt01 | phase1AndPhase2 | Metastatic Melanoma, Melanoma Stage Iii, Melanoma Stage Iv, Recurrent Melanoma (Skin) | Recruiting | MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma | Nov 15, 2022 | ― |
| [203Pb]Vmt-Α-Net, [212Pb]Vmt-Α-Net | phase1AndPhase2 | Gastroenteropancreatic Neuroendocrine Tumor, Neuroendocrine Tumors Unresectable, Neuroendocrine Tumor Metastatic, Bronchial Neuroendocrine Tumor, Paraganglioma, Pheochromocytoma | Recruiting | Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors | Nov 15, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Perspective Therapeutics, Inc. (CATX) have in its pipeline
Perspective Therapeutics CATX is currently developing the following drugs: [203Pb]Pb-Psv359, [212Pb]Pb-Psv359, Nivolumab, [203Pb]Vmt01, [212Pb]Vmt01, [203Pb]Vmt-Α-Net, [212Pb]Vmt-Α-Net. These drug candidates are in various stages of clinical development as the company works toward FDA approval.